Cinchocaine
From Wikipedia, the free encyclopedia
 |
|
|
Cinchocaine
|
|
| Systematic (IUPAC) name | |
| 2-butoxy-N-(2-diethylaminoethyl) quinoline-4-carboxamide | |
| Identifiers | |
| CAS number | |
| ATC code | C05 D04AB02 N01BB06 S01HA06 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H29N3O2 |
| Mol. mass | 343.463 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cinchocaine (or Dibucaine) is an amide local anesthetic.
[edit] External links
- Abdel-Ghani N, Youssef A, Awady M (2005). "Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry.". Farmaco 60 (5): 419-24. PMID 15910814.
- Souto-Padron T, Lima AP, de Oliveira Ribeiro R. (2006). "Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi.". Parasitol Res. PMID 16612626.
- Nounou M, El-Khordagui L, Khalafallah N. "Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles.". Acta Pol Pharm 62 (5): 369-79. PMID 16459486.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
